abagovomab 18
abciximab 19
abituzumab 17
abrilumab 14
actoxumab 9
adalimumab 14
aducanumab 7
afasevikumab 13
alacizumab_pegol 10
alemtuzumab 20
alirocumab 14
amatuximab 27
andecaliximab 17
anifrolumab 17
anrukinzumab 14
aprutumab 9
aprutumab_ixadotin 9
arcitumomab 13
ascrinvacumab 4
atezolizumab 14
atinumab 12
avelumab 8
basiliximab 15
bavituximab 21
begelomab 15
benralizumab 18
bevacizumab_beta 11
bezlotoxumab 9
bimagrumab 10
bleselumab 10
blinatumomab 23
blosozumab 24
bococizumab 11
brazikumab 9
brentuximab_vedotin 17
briakinumab 14
brodalumab 4
brolucizumab 21
brontictuzumab 13
burosumab 14
cabiralizumab 13
camrelizumab 9
canakinumab 20
cantuzumab_ravtansin 32
carlumab 11
carotuximab 19
cergutuzumab_amunaleukin2 21
cergutuzumab_amunaleukin 21
certolizumab_pegol 19
cetiximab 30
citatuzumab_bogatox 22
cixutumumab 16
clivatuzumab_tetraxetan 10
codrituzumab 26
conatumumab 6
concizumab 25
crenezumab 16
crizanlizumab 17
crotedumab 14
dacetuzumab 18
daclizumab 10
dalotuzumab 23
dapirolizumab_pegol 21
daratumumab 12
dectrekumab 8
demcizumab 17
denosumab 8
depatuxizumab 16
depatuxizumab_mafodotin 16
dezamizumab 12
dinutuximab 26
diridavumab 9
domagrozumab 13
drozitumab 9
duligotuzumab 16
durvalumab 4
dusigitumab 0
efalizumab 25
efungumab 21
eldelumab 10
elezanumab 10
elgemtumab 8
elotuzumab 9
emactuzumab 13
emapalumab 22
emibetuzumab 11
enavatuzumab 23
enfortumab_vedotin 8
enoblituzumab 13
enokizumab 18
enoticumab 12
ensituximab 18
eptinezumab 14
erenumab 10
etaracizumab 14
etrolizumab 18
evinacumab 19
evolocumab 3
farletuzumab 3
fasinumab 15
fezakinumab 10
fibatuzumab 3
ficlatuzumab 12
firivumab 21
flanvotumab 8
fletikumab 12
foralumab 7
foravirumab 11
fremanezumab 22
fresolimumab 16
fulranumab 17
futuximab 7
galcanezumab 13
ganitumab 19
gantenerumab 9
gemetuzumab 20
gemtuzumab2 21
gemtuzumab 18
gevokizumab 19
girentuximab 19
glembatumumab 12
glembatumumab_vedotin 12
guselkumab 17
ibalizumab 17
ibritumomab 17
icrucumab 5
idarucizumab 22
ifabotuzumab 3
imalumab 13
imgatuzumab 13
inclacumab 9
indatuximab_ravtansin 17
indusatumab 8
inebilizumab 21
intetumumab 7
iodine_girentuximab 25
ipilimumab 3
iratumumab 6
isatuximab 23
itolizumab 16
ixekizumab 27
labetuzumab_govitecan 15
lambrolizumab 18
lampalizumab 17
lanadelumab 13
landogrozumab 13
laprituximab 19
lebrikizumab 30
lendalizumab 20
lenzilumab 9
lifastuzumab_vedotin 19
ligelizumab 19
lilotomab 27
lirilumab 9
lodelcizumab 8
lokivetmab 21
lorvotuzumab_mertansin 14
lucatumumab 25
lumretuzumab 6
lupartumab 7
lutikizumab 16
margetuximab 23
milatuzumab 27
mirvetuximab 19
mirvetuximab_soravtansin 19
modotuximab 23
mogamulizumab 23
monalizumab 15
motavizumab 21
moxetumomab_pasudotox 16
namilumab 8
naratuximab 21
naratuximab_emtansin 21
narnatumab 12
navicixizumab2 21
navicixizumab 19
navivumab 26
necitumumab 8
nemolizumab 18
nesvacumab 12
nivolumab 7
obiltoxaximab 10
obinutuzumab 28
ocaratuzumab 18
ofatumumab 12
olaratumab 7
olokizumab 19
omalizumab 17
onartuzumab 16
ontuxizumab 16
opicinumab 11
orticumab 9
otelixizumab 26
oxelumab 9
ozanezumab 24
pamrevlumab 5
panobacumab 14
parsatuzumab 19
pasotuxizumab 19
pateclizumab 13
patritumab 14
pembrolizumab 18
perakizumab 13
pidilizumab 13
pinatuzumab_vedotin 14
plozalizumab 23
pogalizumab 19
polatuzumab_vedotin 18
ponezumab 25
prezalumab 11
pritoxaximab 17
quilizumab 17
racotumomab 17
radretumab 12
ralpancizumab 16
ramucirumab 12
ranevetmab 15
ranibizumab 9
refanezumab 17
remtolumab 13
rilotumumab 9
rinucumab 11
risankizumab 29
rituximab 15
rivabazumab 11
robatumumab 19
roledumab 19
romosozumab 16
rontalizumab 19
rosmantuzumab 17
rozanolixizumab 16
sacituzumab 12
sacituzumab_govitecan 12
samalizumab 15
sapelizumab 20
sarilumab 10
secukinumab 8
seribantumab 12
setoxaximab 31
sifalimumab 5
siltuximab 15
simtuzumab 23
sirukumab 7
solanezumab 19
solitomab 15
stamulumab 10
suptavumab 14
suvizumab 10
tabalumab 5
tadocizumab 8
tamtuvetmab 25
tanezumab 18
tarextumab 7
tavolixizumab 11
telisotuzumab 23
teplizumab 15
tesidolumab 14
tezepelumab 19
tigatuzumab 14
tildrakizumab 18
timolumab 7
tisotumab 4
tosatoxumab 22
tositumomab 17
tralokinumab 18
trastuzumab 19
tregalizumab 20
trevogrumab 8
ublituximab 22
urelumab 12
ustekinumab 20
utomilumab 22
vadastuximab 17
vadastuximab_talirin 17
vandortuzumab_vedotin 9
vantictumab 14
vanucizumab2 11
vanucizumab 18
varlilumab 11
vatelizumab 15
vedolizumab 17
veltuzumab 9
vesencumab 9
vorsetuzumab 15
vorsetuzumab_mafodotin 15
vunakizumab 23
xentuzumab 13
zatuximab 23
